Skip to main content

Biomedical Science Award 2021 winners

Investment for the future

CSL Behring had the pleasure of awarding the three best Master's Degrees in Biomedical Sciences at the University of Bern.

07 Apr 2021 Bern Location
COVID Hyperimmune Production

Results from Clinical Trial of COVID-19 Hyperimmune

CoVIg-19 Plasma Alliance Announces Topline Results from NIH-Sponsored Clinical Trial of Investigational COVID-19 Hyperimmune …

coronavirus on a blue background

CSL COVID19 Update

CSL continues to provide medicines to patients around the world.

02 Apr 2021 Company
Life at Biôpole

A Research Catalyst in Switzerland

A new partnership between CSL Behring and Biopôle takes shape, pairing the global biotech with one of the most dynamic life s…

Rare Disease Day Quiz graphic

Take the Rare Disease Day Quiz!

Test your knowledge about rare diseases, which affect more people than you think.

23 Feb 2021 Bern Location
CSL Halbjahresergebnisse 2021

CSL Half Year Results 2020-21

CSL Delivers Net Profit of Over $ 1.8 Billion

18 Feb 2021 Company
Scientist and Corona children's book author Sabine Stoffel Domig with her children.

What to Tell the Kids About COVID-19?

A walk to kindergarten with a group of 5-year-olds gave a CSL Behring scientist an idea for a timely children’s book.

10 Feb 2021 Bern Location

What is a Phase III clinical trial?

A potential hyperimmune treatment for COVID-19 reaches a regulatory milestone in testing its efficacy and safety.

06 Nov 2020 Bern Location
COVID Hyperimmune Production

First Patient Enrolled to Evaluate Potential COVID-19 Hyperimmune Medicine

As co-leader, CSL Behring is very actively involved in this project. The product for the clinical trial phase 3 was manufactu…

09 Oct 2020 Bern Location